ArticleTransplantation and cellular therapy2026

Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research Data.

Matthew J Frigault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.